BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 25864386)

  • 1. The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast.
    Cornejo KM; Deng A; Wu H; Cosar EF; Khan A; St Cyr M; Tomaszewicz K; Dresser K; O'Donnell P; Hutchinson L
    Hum Pathol; 2015 Jun; 46(6):868-75. PubMed ID: 25864386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic utility of MYC amplification and anti-MYC immunohistochemistry in atypical vascular lesions, primary or radiation-induced mammary angiosarcomas, and primary angiosarcomas of other sites.
    Ginter PS; Mosquera JM; MacDonald TY; D'Alfonso TM; Rubin MA; Shin SJ
    Hum Pathol; 2014 Apr; 45(4):709-16. PubMed ID: 24457083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.
    Fernandez AP; Sun Y; Tubbs RR; Goldblum JR; Billings SD
    J Cutan Pathol; 2012 Feb; 39(2):234-42. PubMed ID: 22121953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiosarcoma and atypical vascular lesions of the breast: diagnostic and prognostic role of MYC gene amplification and protein expression.
    Fraga-Guedes C; André S; Mastropasqua MG; Botteri E; Toesca A; Rocha RM; Peradze N; Rotmensz N; Viale G; Veronesi P; Gobbi H
    Breast Cancer Res Treat; 2015 May; 151(1):131-40. PubMed ID: 25893585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fully automated dual-color dual-hapten silver in situ hybridization staining for MYC amplification: a diagnostic tool for discriminating secondary angiosarcoma.
    Ko JS; Billings SD; Lanigan CP; Buehler D; Fernandez AP; Tubbs RR
    J Cutan Pathol; 2014 Mar; 41(3):286-92. PubMed ID: 24329959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.
    Guo T; Zhang L; Chang NE; Singer S; Maki RG; Antonescu CR
    Genes Chromosomes Cancer; 2011 Jan; 50(1):25-33. PubMed ID: 20949568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC gene amplification by fluorescence in situ hybridization and MYC protein expression by immunohistochemistry in the diagnosis of cutaneous angiosarcoma: Systematic review and appropriate use criteria.
    Motaparthi K; Lauer SR; Patel RM; Vidal CI; Linos K
    J Cutan Pathol; 2021 Apr; 48(4):578-586. PubMed ID: 33128474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: clinicopathological, immunohistochemical and molecular analysis of 66 cases.
    Mentzel T; Schildhaus HU; Palmedo G; Büttner R; Kutzner H
    Mod Pathol; 2012 Jan; 25(1):75-85. PubMed ID: 21909081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC immunohistochemistry in angiosarcoma and atypical vascular lesions: practical considerations based on a single institutional experience.
    Udager AM; Ishikawa MK; Lucas DR; McHugh JB; Patel RM
    Pathology; 2016 Dec; 48(7):697-704. PubMed ID: 27780597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-radiation vascular lesions of the breast.
    Ronen S; Ivan D; Torres-Cabala CA; Curry JL; Tetzlaff MT; Aung PP; Nagarajan P; Suster S; Prieto VG
    J Cutan Pathol; 2019 Jan; 46(1):52-58. PubMed ID: 30251277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiation-induced vascular lesions of the skin: an overview.
    Flucke U; Requena L; Mentzel T
    Adv Anat Pathol; 2013 Nov; 20(6):407-15. PubMed ID: 24113311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological and immunohistochemical study of 30 cases of post-radiation atypical vascular lesion of the breast.
    Fraga-Guedes C; Gobbi H; Mastropasqua MG; Rocha RM; Botteri E; Toesca A; Viale G
    Breast Cancer Res Treat; 2014 Jul; 146(2):347-54. PubMed ID: 24943869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of MYC gene amplification on the clinicopathological features and prognosis of radiation-associated angiosarcomas of the breast.
    Kuba MG; Xu B; D'Angelo SP; Rosenbaum E; Plitas G; Ross DS; Brogi E; Antonescu CR
    Histopathology; 2021 Nov; 79(5):836-846. PubMed ID: 34165212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast carcinoma.
    Fineberg S; Rosen PP
    Am J Clin Pathol; 1994 Dec; 102(6):757-63. PubMed ID: 7801888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-radiotherapy vascular proliferations in mammary skin: a clinicopathologic study of 11 cases.
    Mattoch IW; Robbins JB; Kempson RL; Kohler S
    J Am Acad Dermatol; 2007 Jul; 57(1):126-33. PubMed ID: 17572278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can c-myc amplification reliably discriminate postradiation from primary angiosarcoma of the breast?
    Laé M; Lebel A; Hamel-Viard F; Asselain B; Trassard M; Sastre X; Kirova YM
    Cancer Radiother; 2015 May; 19(3):168-74. PubMed ID: 25863565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma: clinicopathologic analysis of 42 cases.
    Brenn T; Fletcher CD
    Am J Surg Pathol; 2005 Aug; 29(8):983-96. PubMed ID: 16006792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical and Fluorescence In Situ Hybridization Analysis of MYC in a Series of 17 Cutaneous Angiosarcomas: A Single-Center Study.
    Requena C; Rubio L; Lavernia J; Machado I; Llombart B; Sanmartín O; Traves V; Guillén C; Cruz J
    Am J Dermatopathol; 2018 May; 40(5):349-354. PubMed ID: 29135507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.
    Shon W; Sukov WR; Jenkins SM; Folpe AL
    Mod Pathol; 2014 Apr; 27(4):509-15. PubMed ID: 24091875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.